Molecular docking, synthesis and biological evaluation of some Imidazo-thiadiazole based Chalcone derivatives as potent triple mutant T790M/C797S EGFR inhibitors
Keywords:
EGFR, imidazo-thiadiazole, in vitro anticancer, apoptosis, cell cycle arrestAbstract
In present study, we have designed and developed some imidazo-thiadiazole based chalcone derivatives as potential EGFR inhibitors. The designed derivative were screened through molecular docking studies and subjected for synthesis followed by in vitro anticancer activity. Most interestingly many molecules had formed one Pi-donor hydrogen bond (Pi-sulfur) or conventional hydrogen bond with Cys797 which is mutated amino acid residue for the second generation EGFR inhibitors. Many molecules had formed Pi-sulfur bond with Met790 which is mutated amino acid residue and developed resistance to the third generation EGFR inhibitors. All the interaction results presented here suggest these molecule has potential to be developed as most potent 4th generation EGFR inhibitors which will might have effectiveness against triple mutant T790M/C797S EGFR. From this investigation, it was decided to synthesize all the designed molecules with their biological evaluation. In vitro cytotoxicity of synthesized compounds against MCF-7 (Breast cancer) and A549 (Lung cancer) cells were carried out using MTT assay. All the synthesized compounds induced the cytotoxicity to MCF-7 and A549 and displayed good range of IC50 values in between 4 to 59 µm/mL.
Downloads
References
Ai, X., Guo, X., Wang, J., Stancu, A. L., Joslin, P. M. N., Zhang, D., & Zhu, S. (2018). Targeted therapies for advanced non-small cell lung cancer. Oncotarget, 9(101), 37589–37607. https://doi.org/10.18632/oncotarget.26428
Akhtar, W., Khan, M. F., Verma, G., Shaquiquzzaman, M., Rizvi, M. A., Mehdi, S. H., Akhter, M., & Alam, M. M. (2017). Therapeutic evolution of benzimidazole derivatives in the last quinquennial period. European Journal of Medicinal Chemistry, 126, 705–753. https://doi.org/10.1016/j.ejmech.2016.12.010
Attili, I., Karachaliou, N., Conte, P. F., Bonanno, L., & Rosell, R. (2018). Therapeutic approaches for T790M mutation positive non-small-cell lung cancer. Expert Review of Anticancer Therapy, 18(10), 1021–1030. https://doi.org/10.1080/14737140.2018.1508347
Bhadoriya, K. S., Kumawat, N. K., Bhavthankar, S. V., Avchar, M. H., Dhumal, D. M., Patil, S. D., & Jain, S. V. (2016). Exploring 2D and 3D QSARs of benzimidazole derivatives as transient receptor potential melastatin 8 (TRPM8) antagonists using MLR and kNN-MFA methodology. Journal of Saudi Chemical Society, 20, S256–S270. https://doi.org/10.1016/j.jscs.2012.11.001
Bhagwat, D. A., Swami, P. A., Nadaf, S. J., Choudhari, P. B., Kumbar, V. M., More, H. N., Killedar, S. G., & Kawtikwar, P. S. (2021). Capsaicin Loaded Solid SNEDDS for Enhanced Bioavailability and Anticancer Activity: In-Vitro, In-Silico, and In-Vivo Characterization. Journal of Pharmaceutical Sciences, 110(1), 280–291. https://doi.org/10.1016/j.xphs.2020.10.020
Bryce, A. H., Rao, R., Sarkaria, J., Reid, J. M., Qi, Y., Qin, R., James, C. D., Jenkins, R. B., Boni, J., Erlichman, C., & Haluska, P. (2012). Phase i study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors. Investigational New Drugs, 30(5), 1934–1941. https://doi.org/10.1007/s10637-011-9742-1
Chan, D. L. H., Segelov, E., Wong, R. S. H., Smith, A., Herbertson, R. A., Li, B. T., Tebbutt, N., Price, T., & Pavlakis, N. (2017). Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer. In Cochrane Database of Systematic Reviews (Vol. 2017, Issue 6). https://doi.org/10.1002/14651858.CD007047.pub2
Chaudhari, R. N., Khan, S. L., Chaudhary, R. S., Jain, S. P., & Siddiqui, F. A. (2020). Β-Sitosterol: Isolation from Muntingia Calabura Linn Bark Extract, Structural Elucidation And Molecular Docking Studies As Potential Inhibitor of SARS-CoV-2 Mpro (COVID-19). Asian Journal of Pharmaceutical and Clinical Research, 13(5), 204–209. https://doi.org/10.22159/ajpcr.2020.v13i5.37909
Chen, L., Fu, W., Zheng, L., Liu, Z., & Liang, G. (2018). Recent Progress of Small-Molecule Epidermal Growth Factor Receptor (EGFR) Inhibitors against C797S Resistance in Non-Small-Cell Lung Cancer. In Journal of Medicinal Chemistry (Vol. 61, Issue 10, pp. 4290–4300). https://doi.org/10.1021/acs.jmedchem.7b01310
Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology, 1263(1263), 243–250. https://doi.org/10.1007/978-1-4939-2269-7_19
Galayev, O., Garazd, Y., Garazd, M., & Lesyk, R. (2015). Synthesis and anticancer activity of 6-heteroarylcoumarins. European Journal of Medicinal Chemistry, 105, 171–181. https://doi.org/10.1016/j.ejmech.2015.10.021
Ghorab, M. M., Ragab, F. A., Heiba, H. I., El-Gazzar, M. G., & Zahran, S. S. (2015). Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives. European Journal of Medicinal Chemistry, 92, 682–692. https://doi.org/10.1016/j.ejmech.2015.01.036
Gil, A., Pabón, A., Galiano, S., Burguete, A., Pérez-Silanes, S., Deharo, E., Monge, A., & Aldana, I. (2014). Synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-Plasmodium falciparum agents. Molecules, 19(2), 2166–2180. https://doi.org/10.3390/molecules19022166
Gokhale, N., Dalimba, U., & Kumsi, M. (2017). Facile synthesis of indole-pyrimidine hybrids and evaluation of their anticancer and antimicrobial activity. Journal of Saudi Chemical Society, 21(7), 761–775. https://doi.org/10.1016/j.jscs.2015.09.003
Grünwald, V., & Hidalgo, M. (2003a). Developing inhibitors of the epidermal growth factor receptor for cancer treatment. In Journal of the National Cancer Institute (Vol. 95, Issue 12, pp. 851–867). https://doi.org/10.1093/jnci/95.12.851
Grünwald, V., & Hidalgo, M. (2003b). Developing inhibitors of the epidermal growth factor receptor for cancer treatment. Journal of the National Cancer Institute, 95(12), 851–867. https://doi.org/10.1093/jnci/95.12.851
Harari, P. M. (2004). Epidermal growth factor receptor inhibition strategies in oncology. In Endocrine-Related Cancer (Vol. 11, Issue 4, pp. 689–708). https://doi.org/10.1677/erc.1.00600
Khan, Sharuk L; Siddiui, F. A. (2020). Beta-Sitosterol: As Immunostimulant, Antioxidant and Inhibitor of SARS-CoV-2 Spike Glycoprotein. Archives of Pharmacology and Therapeutics, 2(1). https://doi.org/10.33696/pharmacol.2.014
Khan, A., Unnisa, A., Sohel, M., Date, M., Panpaliya, N., Saboo, S. G., Siddiqui, F., & Khan, S. (2022). Investigation of phytoconstituents of Enicostemma littorale as potential glucokinase activators through molecular docking for the treatment of type 2 diabetes mellitus. In Silico Pharmacology, 10(1). https://doi.org/10.1007/s40203-021-00116-8
Khan, S., Kale, M., Siddiqui, F., & Nema, N. (2021). Novel pyrimidine-benzimidazole hybrids with antibacterial and antifungal properties and potential inhibition of SARS-CoV-2 main protease and spike glycoprotein. Digital Chinese Medicine, 4(2), 102–119. https://doi.org/10.1016/j.dcmed.2021.06.004
Khan, S.L., Siddiqui, F. A., Jain, S. P., & Sonwane, G. M. (2020). Discovery of Potential Inhibitors of SARS-CoV-2 (COVID-19) Main Protease (Mpro) from Nigella Sativa (Black Seed) by Molecular Docking Study. Coronaviruses, 2(3), 384–402. https://doi.org/10.2174/2666796701999200921094103
Khan, Sharuk L., Siddiqui, F. A., Shaikh, M. S., Nema, N. V., & Shaikh, A. A. (2021). Discovery of potential inhibitors of the receptor-binding domain (RBD) of pandemic disease-causing SARS-CoV-2 Spike Glycoprotein from Triphala through molecular docking. Current Chinese Chemistry, 01. https://doi.org/10.2174/2666001601666210322121802
Khan, Sharuk L., Sonwane, G. M., Siddiqui, F. A., Jain, S. P., Kale, M. A., & Borkar, V. S. (2020). Discovery of Naturally Occurring Flavonoids as Human Cytochrome P450 (CYP3A4) Inhibitors with the Aid of Computational Chemistry. Indo Global Journal of Pharmaceutical Sciences, 10(04), 58–69. https://doi.org/10.35652/igjps.2020.10409
Kumbar, V. M., Peram, M. R., Kugaji, M. S., Shah, T., Patil, S. P., Muddapur, U. M., & Bhat, K. G. (2021). Effect of curcumin on growth, biofilm formation and virulence factor gene expression of Porphyromonas gingivalis. Odontology, 109(1), 18–28. https://doi.org/10.1007/s10266-020-00514-y
Lv, P. C., Li, D. D., Li, Q. S., Lu, X., Xiao, Z. P., & Zhu, H. L. (2011). Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Bioorganic and Medicinal Chemistry Letters, 21(18), 5374–5377. https://doi.org/10.1016/j.bmcl.2011.07.010
Mohana Roopan, S., & Sompalle, R. (2016). Synthetic chemistry of pyrimidines and fused pyrimidines: A review. Synthetic Communications, 46(8), 645–672. https://doi.org/10.1080/00397911.2016.1165254
Peram, M. R., Jalalpure, S., Kumbar, V., Patil, S., Joshi, S., Bhat, K., & Diwan, P. (2019). Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery: in vitro evaluation. Journal of Liposome Research, 29(3), 291–311. https://doi.org/10.1080/08982104.2018.1556292
Rappé, A. K., Casewit, C. J., Colwell, K. S., Goddard, W. A., & Skiff, W. M. (1992). UFF, a Full Periodic Table Force Field for Molecular Mechanics and Molecular Dynamics Simulations. Journal of the American Chemical Society, 114(25), 10024–10035. https://doi.org/10.1021/ja00051a040
Roskoski, R. (2016). Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs. Pharmacological Research, 107, 249–275. https://doi.org/10.1016/j.phrs.2016.03.012
Saavedra, L. M., Ruiz, D., Romanelli, G. P., & Duchowicz, P. R. (2015). Quantitative Structure-Antifungal Activity Relationships for cinnamate derivatives. Ecotoxicology and Environmental Safety, 122, 521–527. https://doi.org/10.1016/j.ecoenv.2015.09.024
San Diego: Accelrys Software Inc. (2012). Discovery Studio Modeling Environment, Release 3.5. Accelrys Software Inc. https://www.3dsbiovia.com/about/citations-references/
Shntaif, A. H., Khan, S., Tapadiya, G., Chettupalli, A., Saboo, S., Shaikh, M. S., Siddiqui, F., & Amara, R. R. (2021). Rational drug design, synthesis, and biological evaluation of novel N-(2-arylaminophenyl)-2,3-diphenylquinoxaline-6-sulfonamides as potential antimalarial, antifungal, and antibacterial agents. Digital Chinese Medicine, 4(4), 290–304. https://doi.org/10.1016/j.dcmed.2021.12.004
Siddiqui, F. A., Khan, S. L., Marathe, R. P., & Nema, N. V. (2021). Design, Synthesis, and In Silico Studies of Novel N-(2-Aminophenyl)-2,3- Diphenylquinoxaline-6-Sulfonamide Derivatives Targeting Receptor- Binding Domain (RBD) of SARS-CoV-2 Spike Glycoprotein and their Evaluation as Antimicrobial and Antimalarial Agents. Letters in Drug Design & Discovery, 18(9), 915–931. https://doi.org/10.2174/1570180818666210427095203
Song, Z., Ge, Y., Wang, C., Huang, S., Shu, X., Liu, K., Zhou, Y., & Ma, X. (2016). Challenges and perspectives on the development of small-molecule EGFR inhibitors against T790M-mediated resistance in non-small-cell lung cancer: Miniperspective. In Journal of Medicinal Chemistry (Vol. 59, Issue 14, pp. 6580–6594). https://doi.org/10.1021/acs.jmedchem.5b00840
Woodburn, J. R. (1999). The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacology and Therapeutics, 82(2–3), 241–250. https://doi.org/10.1016/S0163-7258(98)00045-X
Widana, I.K., Dewi, G.A.O.C., Suryasa, W. (2020). Ergonomics approach to improve student concentration on learning process of professional ethics. Journal of Advanced Research in Dynamical and Control Systems, 12(7), 429-445.
Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
